OQS
RIGL icon

Occudo Quantitative Strategies’s Rigel Pharmaceuticals RIGL Stock Holding History

Occudo Quantitative Strategies’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,389
Closed -$168K – 902
2024
Q3 		$168K Buy
+10,389
New +$122K 0.03% 601

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Occudo Quantitative Strategies's RIGL Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Rigel Pharmaceuticals (RIGL) in Q4 2024, closing a stake of 10,389 shares — an estimated $168K sold.

Occudo Quantitative Strategies first reported a position in RIGL in Q3 2024 and held it in 1 quarter. The position peaked at $168K in Q3 2024. 122 funds tracked by Wall St. Rank hold RIGL as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Rigel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 10,389 Rigel Pharmaceuticals shares in Q4 2024, an estimated $168K.
  • Occudo Quantitative Strategies first reported a position in Rigel Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Rigel Pharmaceuticals position peaked at $168K in Q3 2024.
  • 122 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.